Baidu
map

ISC2019:代谢综合征增加继发性血栓形成风险

2019-02-10 国际循环编辑部 国际循环

众所周知,代谢综合征与多种心血管疾病密切相关。那么,代谢综合征与继发性血栓形成有怎样的关系?代谢综合征可通过哪些途径或机制增加缺血性卒中后继发性血栓形成风险?2019年2月7日,美国卒中协会2019年年会上Jialing Liu教授对相关研究进行系统回顾,从代谢综合征对大脑血流及髓样分化的影响两大方面向参会者就这一问题进行详细解析。

编者按:众所周知,代谢综合征与多种血管疾病密切相关。那么,代谢综合征与继发性血栓形成有怎样的关系?代谢综合征可通过哪些途径或机制增加缺血性卒中后继发性血栓形成风险?2019年2月7日,美国卒中协会2019年年会上Jialing Liu教授对相关研究进行系统回顾,从代谢综合征对大脑血流及髓样分化的影响两大方面向参会者就这一问题进行详细解析。

代谢综合征可定义为以多种代谢性危险因素聚集为特征的临床症候群,如肥胖、高血糖、高血压和血脂异常。相关证据表明,代谢综合征显著增加糖尿病和心脑血管疾病发病率,并且促进患者心脑血管疾病进展,以及增加相关疾病死亡率等。

急性卒中合并代谢障碍患者的卒中类型以缺血性卒中较为多见,同时,代谢综合征也是缺血性卒中的重要独立危险因素,针对性地对其进行干预是预防和治疗缺血性卒中的重要措施。实际上,代谢综合征与卒中的关系不仅如此其还可增加卒中后继发性血栓形成风险。首先,代谢综合征可减少缺血性卒中后软膜侧支血流,导致软膜侧支血流障碍;可影响卒中后穿支动脉血流的恢复。其次,研究发现,代谢综合征还可促进髓样分化。具体来说,其可增加血液中的单核细胞数量并减少淋巴细胞数量。细胞水平的转录组分析更是发现,db/db小鼠中负责Ly6C+向Ly6C-单核细胞转化的转录因子表达受抑制。

进一步深入研究发现,代谢综合征或卒中可增加大脑的巨噬细胞及小胶质细胞。对血液及脑髓系细胞的轨迹推断分析显示,每种轨迹状态中的细胞类型均具有共性。但非卒中db/db小鼠中则呈现独特的细胞状态和转录组模式。另外,研究发现,代谢综合征还可改变血液的流变性。

综上可见,代谢综合征是卒中及其相关并发症防治中不容忽视的重要因素。临床实践中,医生有必要关注和重视代谢综合征的管理,尤其是对于卒中患者。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1724487, encodeId=29181e244870e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Nov 15 07:06:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952675, encodeId=e9f119526e5fe, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Aug 24 01:06:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431442, encodeId=5cea14314428e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587865, encodeId=3eda158e86530, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
    2019-11-15 feifers
  2. [GetPortalCommentsPageByObjectIdResponse(id=1724487, encodeId=29181e244870e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Nov 15 07:06:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952675, encodeId=e9f119526e5fe, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Aug 24 01:06:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431442, encodeId=5cea14314428e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587865, encodeId=3eda158e86530, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
    2019-08-24 xzw113
  3. [GetPortalCommentsPageByObjectIdResponse(id=1724487, encodeId=29181e244870e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Nov 15 07:06:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952675, encodeId=e9f119526e5fe, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Aug 24 01:06:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431442, encodeId=5cea14314428e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587865, encodeId=3eda158e86530, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1724487, encodeId=29181e244870e, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Nov 15 07:06:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952675, encodeId=e9f119526e5fe, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Aug 24 01:06:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431442, encodeId=5cea14314428e, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587865, encodeId=3eda158e86530, content=<a href='/topic/show?id=cb1e1006ebd' target=_blank style='color:#2F92EE;'>#ISC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10067, encryptionId=cb1e1006ebd, topicName=ISC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=173417575755, createdName=yankaienglish, createdTime=Tue Feb 12 07:06:00 CST 2019, time=2019-02-12, status=1, ipAttribution=)]
    2019-02-12 yankaienglish

相关资讯

J Lipid Res:科学家在多不饱和脂肪酸与代谢综合征发病风险研究中取得进展

该研究首次在亚洲人群队列中揭示了n-3和n-6多不饱和脂肪酸(PUFA)与6年代谢综合征发病的关联关系及脂肪酸氧化功能潜在的调控作用。

J Lipid Research:科学家在多不饱和脂肪酸与代谢综合征发病风险研究中取得进展

根据英国曼彻斯特城市大学的一项研究,快餐、蛋糕和加工肉产品等促炎食物(高胆固醇、高饱和脂肪酸和高碳水化合物的食物)的饮食会使患抑郁风险上升40%。

Clin Nutr:维生素D缺乏增加中国青少年和年轻成人代谢综合征风险

北京儿童和青少年代谢综合征研究是一项正在进行的、针对学龄儿童肥胖和相关的心脏代谢状况的前瞻性研究,于2012年开始随访,计划随访10年。研究人员对该研究中559例14~28岁青少年和中国年轻成人的当前数据进行了分析。

Eur Respir J:阻塞性睡眠呼吸暂停是发生代谢综合征的危险因素

由此可见,在一般人群中通过调节夜间低氧血症,OSA与发生MetS风险增加独立相关。

Eur Heart J:房颤患者代谢综合征与非血栓栓塞性心脏不良结局的关系

由此可见,代谢综合征在没有明显CAD的AF患者中很常见,并且导致MACE风险增加,包括MI、冠状动脉血运重建和心脏死亡。鉴于预后意义,预防和治疗MetS可减轻AF患者非血栓栓塞并发症的负担。

J Diabetes Investig:代谢综合征增加糖尿病前期患者心血管风险

一项最新研究结果显示,在中国成人糖尿病前期患者中,代谢综合征使主要心血管事件发生风险增加。

Baidu
map
Baidu
map
Baidu
map